Group items tagged

40th Annual San Antonio Breast Cancer Symposium (SABCS) is organized by UT Health Science Center San Antonio and would be held during Dec 5 - 9, 2017 at Henry B. Gonzalez Convention Center, San Antonio, Texas, United States of America. This cme conference has been approved with a maximum of 38.50 AMA PRA Category 1 Credits. The target audience for this medical event for academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals. Symposium Objective : This Symposium is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer.

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications is organized by American Association for Cancer Research (AACR) and would be held during Oct 26 - 30, 2017 at Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States of America.

Most physicians on Twitter with a financial conflict of interest (FCOI) and frequent tweets mention specific drugs for which they have a conflict, according to a study published in the September issue of The Lancet Haematology. Victoria Kaestner, from the Oregon Health & Science University in Portland, and colleagues examined whether conflicted physicians tweet about specific products for which they have a FCOI. A total of 156 physicians who tweeted a median of 584 times were included, with a 2014 median general payment totaling $13,600. The researchers found that 81 percent of the physicians mentioned at least one drug from a company for which they had a FCOI and 88 percent mentioned at least one drug for which they did not have an FCOI. Fifty-two percent of the 4,358 total drug mentions regarded conflicted drugs. Only 1.3 percent of the physicians included a disclosure relating to their payment; these were in their twitter biography. Conflicted tweets were more likely to be positive, similarly likely to be neutral, and less likely to be negative, compared with tweets about non-conflicted drugs coded at random. "Our results raise the concern that financial conflict of interest must be considered with the growing use of social media to discuss cancer products and practices, as well as policies regarding disclosure, divesture, audit, and recusal may be considered," the authors write.

American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition is organized by American Association of Pharmaceutical Scientists (AAPS) and would be held during Nov 12 - 15, 2017 at San Diego Convention Center, San Diego, California, United States Of America. Course description : This meeting will focus on five themes: * Advanced Formulation Characterization Approaches. * Patient-Centered Innovations in Healthcare Technology. * Products for Pediatrics: It's Not Child's Play. * Improving Inter-organization Collaboration. * Cancer Moonshot: Emerging Modalities for Oncology.